Martinelli; Marisa

Patent Applications and Registrations

Patent applications and USPTO patent grants for Martinelli; Marisa.The latest application filed is for "salts and solid state forms of plinabulin".

Company Profile

1.4.16

Martinelli; Marisa - Villa Guardia IT
Martinelli; Marisa - Baranzate IT
Martinelli; Marisa - Baranzate di Bollate IT
MARTINELLI; Marisa - King of Prussia PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Salts and solid state forms of plinabulin Grant 11,434,225 - Martinelli , et al. September 6, 2	2022-09-06
Salts And Solid State Forms Of Plinabulin App 20210122738 - Martinelli; Marisa ; et al.	2021-04-29
Crystalline Siponimod Fumaric Acid And Polymorphs Thereof App 20210087140 - MARTINELLI; Marisa ; et al.	2021-03-25
Substituted pyrrolo[1,2-A] pyrazines, compositions containing these, processes of making these, and uses thereof Grant 8,334,286 - Ghelardini , et al. December 18, 2	2012-12-18
Nitrogen-containing Bycyclic Compounds Active On Chronic Pain Conditions App 20110015200 - Ghelardini; Carla ; et al.	2011-01-20
Compounds with nootropic action, their preparation, pharmaceutical compositions containing them, and use thereof App 20100173945 - Farina; Carlo ; et al.	2010-07-08
Compounds with nootropic action, their preparation, pharmaceutical compositions containing them, and use thereof Grant 7,732,473 - Farina , et al. June 8, 2	2010-06-08
Compounds with nootropic action, their preperation, pharmaceutical compositions containing them, and use thereof App 20090163565 - FARINA; Carlo ; et al.	2009-06-25
Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents Grant 7,544,705 - Farina , et al. June 9, 2	2009-06-09
3-substituted Quinoline-4-carboxamide Derivatives As Nk-3 And Nk-2 Receptor Antagonists App 20070259882 - FARINA; Carlo ; et al.	2007-11-08
QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 and NK-2 RECEPTOR ANTAGONISTS App 20070161647 - Farina; Carlo ; et al.	2007-07-12
Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents App 20070027137 - Farina; Carlo ; et al.	2007-02-01
Quinoline Derivatives as NK-3 and NK-2 Antagonists App 20070015766 - Farina; Carlo ; et al.	2007-01-18
3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists App 20060229315 - FARINA; Carlo ; et al.	2006-10-12
Quinoline Derivatives as NK-3 Antagonists App 20060223819 - Farina; Carlo ; et al.	2006-10-05
Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists App 20050176762 - Farina, Carlo ; et al.	2005-08-11
3-Substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists App 20040180902 - Farina, Carlo ; et al.	2004-09-16
Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists App 20040152726 - Farina, Carlo ; et al.	2004-08-05
Quinoline derivatives as nk-3 antagonists App 20040097518 - Farina, Carlos ; et al.	2004-05-20
Quinoline derivatives as nk-3 and nk-2 antagonists App 20040082589 - Farina, Carlo ; et al.	2004-04-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.